#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2530	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2152	338.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1701	1701	T	384	T,G	327,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2530	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2152	338.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1435	1435	C	391	C	319	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2530	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2152	338.6	0	HET	.	.	.	G642A,C	.	642	642	G	893	893	G	396	G,A,C	252,66,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2530	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2152	338.6	0	HET	.	.	.	A69G,C	.	69	69	A	320	320	A	355	A,G,C	249,56,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4582	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3907	350.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1883	1883	A	346	A,C	282,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4582	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3907	350.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2517	2517	C	473	C	394	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4582	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3907	350.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2591	2591	A	508	A,T	408,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4582	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3907	350.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3143	3143	C	399	C,T,A	309,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	404	folP	852	852	99.88	folP.l15.c4.ctg.1	1810	66.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	966	968	AAA	90;90;90	A,T;A;A	68,1;68;69	.	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	404	folP	852	852	99.88	folP.l15.c4.ctg.1	1810	66.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1197	1199	AGC	83;83;83	A,C;G;C	69,1;71;66	folP.WHO_U_01433c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	784	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3589	65.0	1	SNP	p	S91F	0	.	.	271	273	TCC	629	631	TCC	58;58;59	T;C;C	42;47;49	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	784	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3589	65.0	1	SNP	p	D95G	0	.	.	283	285	GAC	641	643	GAC	61;61;61	G;A;C	50;49;48	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	784	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3589	65.0	1	SNP	p	D95N	0	.	.	283	285	GAC	641	643	GAC	61;61;61	G;A;C	50;49;48	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	356	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1687	63.1	1	SNP	p	G45D	0	.	.	133	135	GGC	732	734	GGC	113;112;111	G;G;C	87;88;90	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	166	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1246	39.9	0	.	n	.	0	A197.	DEL	197	197	A	770	770	A	83	A	66	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	804	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3307	72.9	1	SNP	p	D86N	0	.	.	256	258	GAC	748	750	GAC	78;78;78	G;A,C;C	68;66,1;68	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	804	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3307	72.9	1	SNP	p	S87R	0	.	.	259	261	AGT	751	753	AGT	79;80;78	A;G;T	67;70;69	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	804	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3307	72.9	1	SNP	p	S87I	0	.	.	259	261	AGT	751	753	AGT	79;80;78	A;G;T	67;70;69	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	804	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3307	72.9	1	SNP	p	S87W	0	.	.	259	261	AGT	751	753	AGT	79;80;78	A;G;T	67;70;69	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	804	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3307	72.9	1	SNP	p	S88P	0	.	.	262	264	TCC	754	756	TCC	78;79;79	T;C;C	68;66;71	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	730	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3071	71.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1732	1734	GGC	104;104;105	G;G;C	80;78;80	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	606	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2768	65.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1483	1485	GCA	96;95;94	G;C;A	87;84;84	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	606	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2768	65.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1486	1488	ATC	95;95;95	A;T,C;C	88;85,1;86	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	606	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2768	65.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1498	1500	GTG	99;98;98	G;T;G	87;84;81	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	606	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2768	65.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1498	1500	GTG	99;98;98	G;T;G	87;84;81	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	606	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2768	65.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2002	2004	ACC	59;59;59	A;C;C	51;49;51	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	606	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2768	65.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2056	2058	GCG	59;59;59	G;C;G	46;42;47	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	606	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2768	65.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2056	2058	GCG	59;59;59	G;C;G	46;42;47	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	606	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2768	65.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2179	2181	GGC	60;59;58	G;G;C	52;51;51	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	606	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2768	65.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2188	2190	GGC	56;56;55	G;G;C	48;47;47	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	606	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2768	65.5	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2206	2208	CTG	55;55;55	C;T;G	45;46;48	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	908	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3462	78.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1794	1796	CCG	76;76;75	C,G;C;G	58,1;59;59	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	454	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2214	61.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	817	817	C	63	C	48	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	548	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1804	89.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	557	559	GAA	112;112;113	G;A;A	93;94;93	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	548	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1804	89.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	845	847	GAT	103;105;106	G;A;T	86;86;86	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	548	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1804	89.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	968	970	TCA	117;118;119	T;C;A	92;98;98	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	548	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1804	89.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1097	1099	GTC	131;132;131	G;T;C	108;112;109	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	548	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1804	89.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1109	1111	TCT	125;128;128	T;C;T	100;108;109	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	548	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1804	89.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1427	1429	GCA	120;119;117	G;C;A	94;93;85	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	548	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1804	89.3	1	SNP	p	G120K	1	.	.	358	360	AAG	803	805	AAG	105;106;107	A;A,G;G	87;89,1;91	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	548	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1804	89.3	1	SNP	p	D121N	0	.	.	361	363	GAC	806	808	GAC	107;108;108	G;A;C	90;86;91	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	548	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1804	89.3	1	SNP	p	A121D	1	.	.	361	363	GAC	806	808	GAC	107;108;108	G;A;C	90;86;91	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1846	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5111	107.9	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2119	2121	AAT	103;102;102	A,C;A;T	90,1;90;93	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	260	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1476	52.6	1	SNP	p	V57M	1	.	.	169	171	ATG	777	779	ATG	105;105;105	A;T,G;G	85;86,1;86	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
